Shopping Cart
Remove All
Your shopping cart is currently empty
Anti-Apolipoprotein A-II/APOA2 Antibody (4X421) is an antibody targeting Apolipoprotein A-II/APOA2. Anti-Apolipoprotein A-II/APOA2 Antibody (4X421) can be used in ELISA,FCM,IHC,WB.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 50 μL | $207 | 7-10 days | 7-10 days | |
| 100 μL | $347 | 7-10 days | 7-10 days |
| Description | Anti-Apolipoprotein A-II/APOA2 Antibody (4X421) is an antibody targeting Apolipoprotein A-II/APOA2. Anti-Apolipoprotein A-II/APOA2 Antibody (4X421) can be used in ELISA,FCM,IHC,WB. |
| Synonyms | ProapoA-II, Apolipoprotein A-II(1-76), Apolipoprotein A-II, Apolipoprotein A2, Apo-AII, APOA2 |
| Ig Type | Rabbit IgG |
| Clone | 4X421 |
| Reactivity | Human |
| Verified Activity | 1. Western Blot -Positive WB detected in: 293T whole cell lysate, A549 whole cell lysate -All lanes: Apolipoprotein A II antibody at 0.87μg/ml -Secondary: Goat polyclonal to rabbit IgG at 1/50000 dilution -Predicted band size: 12 KDa -Observed band size: 12 KDa 2. IHC image of TMAH-00070 diluted at 1:87.5 and staining in paraffin-embedded human liver tissue performed on a Leica BondTM system. After dewaxing and hydration, antigen retrieval was mediated by high pressure in a citrate buffer (pH 6.0). Section was blocked with 10% normal goat serum 30min at RT. Then primary antibody (1% BSA) was incubated at 4°C overnight. The primary is detected by a biotinylated secondary antibody and visualized using an HRP conjugated SP system. 3. Overlay histogram showing A549 cells stained with TMAH-00070 (red line) at 1:50. The cells were fixed with 70% Ethylalcohol (18h) and then permeabilized with 0.3% Triton X-100 for 2 min. The cells were then incubated in 1x PBS /10% normal goat serum to block non-specific protein-protein interactions followed by primary antibody for 1 h at 4°C. The secondary antibody used was FITC goat anti-rabbit IgG (H+L) at 1/200 dilution for 1 h at 4°C. Control antibody (green line) was used under the same conditions. Acquisition of >10,000 events was performed. |
| Application | |
| Recommended Dose | WB:1:500-1:5000; IHC:1:50-1:200. |
| Antibody Type | Monoclonal |
| Subcellular Localization | Secreted. |
| Tissue Specificity | Plasma; synthesized in the liver and intestine. |
| Construction | Recombinant Antibody |
| Purification | Affinity-chromatography |
| Appearance | Liquid |
| Formulation | Phosphate buffered saline, pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol. |
| Research Background | May stabilize HDL (high density lipoprotein) structure by its association with lipids, and affect the HDL metabolism. |
| Conjucates | Unconjugated |
| Immunogen | A synthetic peptide: Human APOA2 |
| Antigen Species | Human |
| Gene Name | APOA2 |
| Gene ID | |
| Uniprot ID | |
| Biology Area | Cardiovascular |
| Stability & Storage | Store at -20°C or -80°C for 12 months. Avoid repeated freeze-thaw cycles. |
| Transport | Shipping with blue ice. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.